SCHEMBL5164423

SCHEMBL5164423

COc1ccc(NC(=O)Cc2ccc(N)cc2N)c(OC)c1

nearest known ligand 0.63

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.63
USP2 O75604 1/20 0.56
MAPT P10636 2/20 0.55
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
LMNA P02545 1/20 0.52
HPGD P15428 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
KMT2A Q03164 3/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
HTT P42858 1/20 0.49
MEN1 O00255 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL5307185 0.99 ALDH1A1 (0.61) ALDH1A1USP2MAPTNPC1RAB9A
SCHEMBL19427445 0.86 ALDH1A1 (0.75) ALDH1A1USP2MAPTNPC1RAB9A
SCHEMBL5163481 0.85 TSHR (0.56) ALDH1A1MAPTLMNASMN1; SMN2KMT2A
SCHEMBL5162960 0.82 ALDH1A1 (0.55) ALDH1A1MAPTNPC1RAB9ALMNA
SCHEMBL5164776 0.82 ALDH1A1 (0.61) ALDH1A1USP2MAPTNPC1RAB9A
SCHEMBL19427444 0.82 ALDH1A1 (0.73) ALDH1A1USP2MAPTNPC1RAB9A
SCHEMBL5162820 0.79 USP2 (0.61) ALDH1A1USP2MAPTNPC1RAB9A
Ammonia Solution, Strong SCHEMBL5306333 0.78 USP2 (0.60) ALDH1A1USP2MAPTNPC1RAB9A
SCHEMBL19427481 0.77 KMT2A (0.68) ALDH1A1MAPTCYP1A2CYP2C9CYP2C19
SCHEMBL10852085 0.76 ALDH1A1 (0.82) ALDH1A1USP2MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070067923-A1 1,3-Diaminobenzene derivatives and colorants comprising these compounds PROCTER & GAMBLE COMPANY, THE 2007-03-29 US claimed
WO-2007026312-A1 1,3-DIAMINOBENZENE DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2007-03-08 WO claimed
EP-1760072-A1 1,3-diaminobenzene derivatives and colorants comprising these compounds Wella Aktiengesellschaft (DE) 2007-03-07 EP claimed
US-20070067923-A1 1,3-Diaminobenzene derivatives and colorants comprising these compounds PROCTER & GAMBLE COMPANY, THE 2007-03-29 US disclosed
WO-2007026312-A1 1,3-DIAMINOBENZENE DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2007-03-08 WO disclosed
EP-1760072-A1 1,3-diaminobenzene derivatives and colorants comprising these compounds Wella Aktiengesellschaft (DE) 2007-03-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070067923-A1 1,3-Diaminobenzene derivatives and colorants comprising these compounds KRT18, DSP, DSG1 ALDH1A1 12/4885USP2 4024/4885MAPT 1737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.